Previous 10 | Next 10 |
2023-08-03 14:43:45 ET TRxADE HEALTH ( NASDAQ: MEDS ), parent company of pharmaceutical B2B exchange platform, which recently merged with Superlatus, Thursday announced the appointment of Forbes Fisher as Chief Operating Officer It also named Dr. Eugenio B...
Forbes Fisher Appointed as Chief Operating Officer . Dr. Eugenio Bortone Appointed as Chief Innovation & Food Technology Officer . TAMPA, FL, Aug. 03, 2023 (GLOBE NEWSWIRE) -- TRxADE HEALTH, Inc (NASDAQ: MEDS), parent company of pharmaceutical B2B exc...
2023-08-02 10:17:25 ET Gainers: TRxADE HEALTH ( MEDS ) +60% . Armata Pharmaceuticals ( ARMP ) +17% . Teva Pharmaceutical Industries ( TEVA ) +13% . CareDx ( CDNA ) +9% . Mallinckrodt ( MNK ) +9% . Losers: Adamis Pharmaceut...
2023-08-02 08:53:47 ET Advanced Health Intelligence ( AHI ) +34% to re-enter China with Exclusive License Deal with Changlin Network Technology Ltd. Rubicon Technologies ( RBT ) +29% . Smart for Life ( SMFL ) +17% . Cardlytics ( CDLX ) +22% ...
TAMPA, FL / ACCESSWIRE / July 31, 2023 / TRxADE HEALTH INC. (NASDAQ:MEDS) , is a health services IT company focused on digitalizing the retail pharmacy experience by optimizing drug procurement, the prescription journey and patient engagement in the U.S., will release financial results for the ...
NEW YORK, July 31, 2023 (GLOBE NEWSWIRE) -- TRxADE HEALTH, Inc. (NASDAQ: MEDS) (“TRxADE”), a pharmaceutical exchange platform provider, today announced the closing of the previously announced acquisition of Superlatus, Inc. (“Superlatus”), a U.S.-based holding company ...
TRxADE Health (NASDAQ: MEDS) , a health-services IT company focused on digitalizing the retail pharmacy experience by optimizing drug procurement, the prescription journey and patient engagement in the United States, released an amended and restated merger agreement with Superlatus Inc. Supe...
2023-07-14 17:06:25 ET TRxADE HEALTH ( NASDAQ: MEDS ) on Friday said it had amended and restated its merger agreement with Superlatus, a U.S.-based holding company of food products and distribution capabilities. The parties entered into the original merger agreement on Ju...
NEW YORK, July 14, 2023 (GLOBE NEWSWIRE) -- TRxADE HEALTH, Inc. (NASDAQ: MEDS) (“TRxADE”), a pharmaceutical exchange platform provider, announced today that it entered into an amended and restated merger agreement with Superlatus, Inc. (“Superlatus”), a U.S.-based hold...
2023-06-30 12:16:06 ET Superlatus has signed a definitive agreement to be acquired by TRxADE HEALTH ( NASDAQ: MEDS ), a pharmaceutical exchange platform provider. Upon closing of the Merger, shareholders of Superlatus will receive an aggregate of 173,463 shares of MEDS sto...
News, Short Squeeze, Breakout and More Instantly...
TRxADE (NASDAQ: MEDS) today announced that its board of directors has declared a special cash dividend of $1.50 per share of common stock. According to the announcement, the special dividend is being paid using a portion of the proceeds received in May 2024 in connection with the prior sale of t...
A look at the top 10 most actives in the United States Faraday Future Intelligent Electric Inc. (FFIE) rose 20.9% to $0.5541 on volume of 173,316,620 shares Assure Holdings Corp. (IONM) rose 114.1% to $0.496799 on volume of 118,668,589 shares NLS Pharmaceutics Ltd. (NLSP) rose 67.6% to $0...
TAMPA, FL, June 27, 2024 (GLOBE NEWSWIRE) -- TRxADE HEALTH Inc. ( Nasdaq: MEDS ) (the “ Company ”), announced today that with the filing of its Quarterly Report on Form 10-Q for the period ended March 31, 2024 (the “Form 10-Q”), the Company regained complianc...